Abstract
In the search of efficient anticancer agents, here, new 5-(4-alkylbenzyledene)thiazolidine-2,4-dione derivatives (5a–g) have been successfully synthesized and characterized and are evaluated for anticancer and antimicrobial activities using DNA cleavage studies. In vitro studies on anticancer activity of compound 5d (NSC: 768619/1) was done against the full panel of 60 human tumor cell lines. The five-level dose activity results revealed that, the compound 5d was active against all the cell lines, it has shown potential activity against leukemia SR (GI50: 2.04 μM), non-small cell lung cancer NCI-H522 (GI50: 1.36 μM), colon cancer COLO 205 (GI50: 1.64 μM), CNS cancer SF-539 (GI50: 1.87 μM), melanoma SK-MEL-2 (GI50: 1.64 μM), ovarian cancer OVCAR-3 (GI50: 1.87 μM), renal cancer RXF 393 (GI50: 1.15 μM), prostate cancer PC-3 (GI50: 1.90 μM), and breast cancer MDA-MB-468(GI50: 1.11 μM). DNA cleavage studies revealed that at 50 μg/mL concentration, partial DNA digestion was observed and when the concentration is increasing to threefold (150 μg/mL), complete linear DNA digestion and partial supercoiled DNA digestion was observed. Further antimicrobial studies indicate that all the synthesized compounds except compound 5a possess prominent activity against all the screened microbial species. This study throws a ray of light in the field of anticancer drugs.
Similar content being viewed by others
References
Albrand G, Terret C (2008) Early breast cancer in the elderly: assessment and management considerations. Drugs Aging 25:35–45
Zheng H, Dong Y, Lin L, Sun B, Liu L, Yuan H, Lou H (2016) Novel benzo[a]quinolizidine analogs induce cancer cell death through paraptosis and apoptosis. J Med Chem 59:5063–5076
Salton MRJ, Kim KS (1996) Structure in: Baron’s medical microbiology (Baron S et al., eds) (4th ed)
Frisk-Holmberg M, van der Kleijn E (1972) The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release. Eur J Pharmacol 18:139–147
Tse B, Balkovec JM, Blazey CM, Hsu MJ, Nielsen J, Schmatz D (1998) Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast. Bioorg Med Chem Lett 8:2269–2272
Johnston AD. U. S. Pat. Appl. US.2003215635 (2003) Materials for reshaping of essentially rigid keratinaceous surfaces
Shaikh SA, Ahmed SR, Jayaram B (2004) A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minor-groove binders. Arch Biochem Biophys 429:81–99
Tomasic T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP (2010) Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones. Eur J Med Chem 45:1667–1672
Ljungman M (2009) Targeting the DNA damage response in cancer. Chem Rev 109:2929–2950
Chandrappa S, Kavitha CV, Shahabuddin MS, Vinaya K, Ananda Kumar CS, Ranganatha SR, Raghavan SC, Rangappa KS (2009) Synthesis of 2-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells. Bioorg Med Chem 17:2576–2584
Azizmohammadi M, Khoobi M, Ramazani A, Emami S, Zarrin A, Firuzi O, Miri R, Shafiee A (2013) 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Eur J Med Chem 59:15–22
Romagnoli R, Baraldi PG, Salvador MK, Encarnacion Camacho M, Balzarini J, Bermejo J, Estévez F (2013) Anticancer activity of novel hybrid molecules containing 5-benzylidene thiazolidine-2,4-dione. Eur J Med Chem 62:544–557
Barros FWA, Goncalves Silva T, Galdino da Rocha Pitta M, Bezerra DP, Costa-Lotufo LV, De Moraes MO, Pessoa C, De Moura MAFB, De Abreu FC, de Lima M d CA, Lins Galdino S, Da Rocha Pitta I, Goulart MOF (2012) Synthesis and cytotoxic activity of new acridine-thiazolidine derivatives. Bioorg Med Chem 20:3533–3539
Nitsche C, Schreier VN, Mira A, Behnam M, Kumar A, Bartenschlager R, Klein CD (2013) Thiazolidinone–peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. J Med Chem 56:8389–8403
Pattan S, Kedar M, Pattan J, Dengale S, Snap M, Gharate U, Shinde P, Kadam S (2012) Synthesis and evaluation of some novel 2,4 thiazolidine dione derivatives for antibacterial, antitubercular and antidiabetic derivatives. Indian J Chem 51B:1421–1425
Srebnik M, Polacheck I, Steinberg D, Jabbour A, Sionov E (2010)Novel Anti-Biofilm Agents. WO2010/058402 A1
Ponnuchamy S, Kanchithalaivan S, Kumar RR, Ali MA, Choon TS (2014) Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones. Bioorg Med Chem Lett 24:1089–1093
Asati V, Mahapatra DK, Bharti SK (2014) Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: potential anticancer agents. Eur J Med Chem 87:814–833
Chadha N, Bahia MS, Kaur M, Silakari O (2015) Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions. Bioorg Med Chem 23:2953–2974
Zidar N, Tomasic T, Sink R, Rupnik V, Kovac A, Turk S, Patin D, Blanot D, Martel CC, Dessen A, Premru MM, Zega A, Gobec S, Kikelj D (2010) Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. J Med Chem 53:6584–6594
Kim BY, Ahn JB, Lee HW, Kang SK, Lee JH, Shin JS, Ahn SK, Hong CI, Yoon SS (2004) Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione. Eur J Med Chem 39:433–447
Robert GG, Norman JL, John KQ, Michael JS, Michael WJU, Latifa Y (2000) Regiospecific reduction of 5- benzylidene-2,4-thiazolidinediones and 4-oxo-2-thiazolidinethiones using lithium borohydride in pyridine and tetrahydrofuran. Tetrahedron 56:4531–4537
Chen H, Fan YH, Natarajan A, Guo Y, Iyasere J, Harbinski F, Luus L, Christ W, Aktas H, Halperin JA (2004) Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation. Bioorg Med Chem Lett 14:5401–5405
Bruno G, Costantino L, Curinga C, Maccari R, Monforte F, Nicolo F, Ottana R, Vigorita MG (2002) Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. Bioorg Med Chem 10:1077–1084
National Committee for Clinical Laboratory Standards (NCCLS) (1982) National Committee for Clinical Laboratory Standards, Villanova, p 242
Linday ME (1962) Practical introduction to microbiology, E and F. N. 436. Spon Ltd., New York, p. p 17
Usoy MCU, Dundar OB, Altanlar N, Ertan R (2006) Synthesis and antimicrobial activity of some new 3-substituted benzyl-5-(4-chloro-2-piperidin-1ylthiazole-5-yl-methylene)-thiazolidine-2,4-dione derivatives. Turk J Chem 30:355–360
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601
Zaharevitz DW, Holbeck SL, Bowerman C, Svetlik PA (2002) Compare: a web accessible tool for investigating mechanisms of cell growth inhibition. J Mol Graph Model 20:297–303
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor
Acknowledgments
The authors wish to thank NCI/NIH, Bethesda, USA, for performing the antitumor testing of the synthesized compounds, and one of the authors (RG) is thankful to the Ministry of Human Resource Development, New Delhi for providing the fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests. The authors alone hereby stand responsible for the contents of this scientific paper.
Open access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original authors and the source are credited.
Ethical statements
This article does not contain any studies with human participants or animals performed by any of the authors.
Electronic supplementary material
ESM 1
(DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Laxmi, S.V., Anil, P., Rajitha, G. et al. Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies. J Chem Biol 9, 97–106 (2016). https://doi.org/10.1007/s12154-016-0154-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12154-016-0154-8